PRACA ORYGINALNA
Opóźnienia diagnostyczne w chorobach reumatycznych z towarzyszącym zapaleniem stawów
Więcej
Ukryj
Data nadesłania: 06-07-2017
Data ostatniej rewizji: 13-08-2017
Data akceptacji: 15-08-2017
Data publikacji online: 31-08-2017
Data publikacji: 31-08-2017
Reumatologia 2017;55(4):169-176
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Objective: The objective of this study was to determine the length of delay in diagnosis of inflammatory rheumatic diseases, and to indicate the main factors responsible for such delays.
Material and methods: A retrospective multi-centre questionnaire survey carried out among 197 patients with diagnosed inflammatory rheumatic diseases or undergoing the diagnostic process.
Results: The most common early symptoms of inflammatory rheumatic disease included joint pain (94%), joint swelling (78%), morning joint stiffness (77%), fatigue (76%), and sleep disturbed by joint pain (74%). When asked about the reasons for seeking medical help, most patients indicated intensification of the symptoms (89%) and the fact that the symptoms made them unable to perform daily activities or work (86%). Limited access to specialists (70%) and the conviction that the symptoms will resolve spontaneously (57%) had the biggest impact on delaying a visit to a doctor. Before visiting a rheumatologist, the patients consulted their symptoms with their general practitioners (GPs, 95%), orthopaedicians (43%), and neurologists (29%). Almost half of the patients (48%) consulted their symptoms with at least 2 non-rheumatologists, whereas as many as 21% of patients visited 4 or more specialists. After the onset of symptoms of rheumatic disease, 28% of patients delayed seeing any doctor for 4 months or longer. 36% of patients waited 4 months or longer for a referral to a rheumatologist. The great majority of the patients (85%) made an appointment with a rheumatologist within a month of receiving a referral. 25% of patients waited 4 months or longer to see a rheumatologist.
Conclusions: Diagnostic delays result from both the level of patients’ awareness (ignoring early symptoms) and improper functioning of the health care system. In the case of the health care system, the source of delays is not only “queues to rheumatologists”, but also referring patients to non-rheumatologists.
REFERENCJE (18)
1.
Van Eijk IC, Nielen MMJ, Van der Horst-Bruinsma I, et al. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Rheumatology 2012; 51: 686-694.
2.
Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017; 76: 960-977.
3.
Raza K, Saber TP, Kvien TK, et al. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration In clinical trials. Ann Rheum Dis 2012; 71: 1921-1923.
4.
Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23: 61-66.
5.
van der Linden MP, Cessie S, Raza K, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010; 62: 3537-3546.
6.
Stack RJ, Shaw K, Mallen C, et al. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann Rheum Dis 2012; 71: 493-497.
7.
Atzeni F, Sarzi-Puttini P. Rheumatoid arthritis: Why wait? Explaining delays in seeking therapy for early arthritis. Nat Rev Rheumatol 2012; 8: 190-191.
8.
Gremese E, Salaffi F, Bosello SL, et al. Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis 2013; 22: 858-862.
9.
van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis 2017; 76: 491-496.
10.
Filipon E, Brazier M, Clavel G, et al. Is it possible to identify early predictors of the future cost of chronic arthritis? The VErA project. Fundam Clin Pharmacol 2009; 23: 105-113.
11.
Mølbaek K, Hørslev-Petersen K, Primdahl J. Diagnostic Delay in Rheumatoid Arthritis: A Qualitative Study of Symptom Interpretation Before the First Visit to the Doctor. Musculoskeletal Care 2016; 14: 26-36.
12.
Barnabe C, Xiong J, Pope JE, et al. Factors associated with time to diagnosis in early rheumatoid arthritis. Rheumatol Int 2014; 34: 85-92.
13.
Villeneuve E, Nam JL, Bell MJ, et al. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Ann Rheum Dis 2013; 72: 13-22.
14.
Raza K, Stack R, Kumar K, et al. Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 2011; 70: 1822-1825.
15.
Ozbek S, Sert M, Paydas S, et al. Delay in the Diagnosis of SLE: The Importance of Arthritis/Arthralgia as the Initial Symptom. Acta Med Okayma 2003; 57: 187-190.
16.
Firth J, Snowden N, Ledingham J, et al. The 1st National Clinical audit for Rheumatoid and Early Inflammatory Arthritis: findings and implications for nursing practice. Br J Nurs 2016; 25: 613-617.
17.
Kwiatkowska B, Raciborski F, Maślińska M, et al. Wczesna diagnostyka chorób reumatycznych – ocena obecnej sytuacji i rekomendacje zmian. Instytut Reumatologii w Warszawie, Warszawa 2014.
18.
Kotarba-Kańczugowska M, Kucharski K, Linder-Kopiecka I, et al. JA PACJENT! Perspektywa Organizacji Pacjenckich na Stan Opieki Reumatologicznej w Polsce. Raport Organizacji Pacjenckich, Warszawa 2014.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.